Success Metrics

Clinical Success Rate
75.0%

Based on 6 completed trials

Completion Rate
75%(6/8)
Active Trials
1(11%)
Results Posted
0%(0 trials)
Terminated
2(22%)

Phase Distribution

Ph phase_1
1
11%
Ph not_applicable
8
89%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution9 total trials
Phase 1Safety & dosage
1(11.1%)
N/ANon-phased studies
8(88.9%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

75.0%

6 of 8 finished

Non-Completion Rate

25.0%

2 ended early

Currently Active

1

trials recruiting

Total Trials

9

all time

Status Distribution
Active(1)
Completed(6)
Terminated(2)

Detailed Status

Completed6
Terminated2
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
1
Success Rate
75.0%
Most Advanced
Phase 1

Trials by Phase

Phase 11 (11.1%)
N/A8 (88.9%)

Trials by Status

active_not_recruiting111%
completed667%
terminated222%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
9